Fractional exhaled Nitric Oxide in Patients with Immunodeficiency v1

• Research type

  Research Study

• Full title

  A prospective cohort study to determine the utility of fractional exhaled nitric oxide measurement in the assessment of patients with antibody deficiency.

• IRAS ID

  297445

• Contact name

  Stephen Jolles

• Contact email

  stephen.jolles@wales.nhs.uk

• Sponsor organisation

  Cardiff and Vale University Health Board

• Duration of Study in the UK

  1 years, 0 months, 0 days

• Research summary

  > To determine if Fractional exhaled Nitric Oxide (FeNO) levels in the lungs and upper airways are statistically different in immunodeficient patients to data from non-immunodeficient people
  >Single site study in an NHS outpatient setting
  > Participants will be in the study for a year.
  > Participants will need to complete questionnaires at their routine clinic appointments

• REC name

  London - Camberwell St Giles Research Ethics Committee

• REC reference

  21/PR/0924

• Date of REC Opinion

  13 Jul 2021

• REC opinion

  Favourable Opinion